Quarterly report pursuant to Section 13 or 15(d)

Acquisitions, Investments, and Licenses - Schedule of Pro Forma (Details)

v3.3.0.814
Acquisitions, Investments, and Licenses - Schedule of Pro Forma (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Bio-Reference        
Business Acquisition [Line Items]        
Revenues $ 282,461 $ 241,826 $ 813,018 $ 670,280
Net income (loss) 121,086 (25,282) (7,507) (90,990)
Net income (loss) attributable to common shareholders 121,086 (23,937) (6,107) (67,841)
EirGen        
Business Acquisition [Line Items]        
Revenues 143,034 22,730 219,803 75,470
Net income (loss) 128,247 (49,834) (34,084) (125,657)
Net income (loss) attributable to common shareholders $ 128,247 $ (48,489) $ (32,684) $ (123,176)